4//SEC Filing
Lee Tien-Li 4
Accession 0001193125-25-241647
CIK 0001774857other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 6:14 PM ET
Size
7.6 KB
Accession
0001193125-25-241647
Insider Transaction Report
Form 4
Lee Tien-Li
DirectorChief Executive Officer10% Owner
Transactions
- Exercise/Conversion
Stock option (right to buy)
2025-10-15−1,229→ 40,566 totalExercise: $4.24Exp: 2034-07-20→ Common Stock (1,229 underlying) - Exercise/Conversion
Common Stock
2025-10-15$4.24/sh+1,229$5,211→ 1,544,613 total
Holdings
- 1,474,028(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]1/48th of the original number of shares subject to the option vested on July 27, 2024, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.
Documents
Issuer
Aardvark Therapeutics, Inc.
CIK 0001774857
Entity typeother
Related Parties
1- filerCIK 0001940120
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 6:14 PM ET
- Size
- 7.6 KB